About NovaVision
NovaVision is a company based in Boca Raton (United States) founded in 2003. It operates as a HealthTech and Subscription Services. NovaVision has raised $38 million across 3 funding rounds from investors including Johnson & Johnson Innovation – JJDC, Oakwood Medical and Tullis Health Investors. NovaVision has completed 1 acquisition, including Sight Science. NovaVision offers products and services including Vision Restoration Therapy (VRT) and NeuroEyeCoach. NovaVision operates in a competitive market with competitors including Newronika, Sight Science, EnClear Therapies, MindAffect and AccuMedical, among others.
- Headquarter Boca Raton, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novavision Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jan 09, 2007
-
Investors
Johnson & Johnson Innovation – JJDC
& 4 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NovaVision
NovaVision offers a comprehensive portfolio of products and services, including Vision Restoration Therapy (VRT) and NeuroEyeCoach.
Therapy is designed to restore vision post-injury.
Program is developed to improve eye movement efficiency.
People of NovaVision
Unlock access to complete
Unlock access to complete
Funding Insights of NovaVision
NovaVision has successfully raised a total of $38M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NovaVision
NovaVision has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovation – JJDC, Oakwood Medical and Tullis Health Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Growth stage VC fund investing in the US, Europe and Canada
|
Locked | Locked | Locked | |
|
Healthcare investments are made by Tullis Health Investors.
|
Locked | Locked | Locked |
Investor details for NovaVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NovaVision
NovaVision has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sight Science.
Investment portfolio details for NovaVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Visual rehabilitation for brain-injured patients with field loss is provided.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for NovaVision
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NovaVision
Detailed financials for NovaVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novavision Comparisons
Peer comparison for NovaVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NovaVision
NovaVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newronika, Sight Science, EnClear Therapies, MindAffect and AccuMedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Visual rehabilitation for brain-injured patients with field loss is provided.
|
|
| Locked | Locked | Locked |
Developer of device-based therapies to treat neurodegenerative disorders
|
|
| Locked | Locked | Locked |
Brain-computer interface headsets are developed for patient communication.
|
|
| Locked | Locked | Locked |
Neurovascular interventional devices for neurological disorders are developed.
|
Detailed competitors of NovaVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novavision
Complete news archive for NovaVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovaVision
NovaVision was founded in 2003.
NovaVision is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
NovaVision is a funded company, having raised a total of $38M across 3 funding rounds to date.
NovaVision is engaged in providing therapies for vision loss caused by neurological conditions such as stroke or brain injury. Solutions are offered in the healthcare sector, specifically targeting vision rehabilitation. Two primary therapies, Vision Restoration Therapy (VRT) and NeuroEyeCoach, are developed to help patients recover and adapt to vision impairments. These evidence-based programs are supported by scientific research and clinical studies, aiming to improve patients quality of life through innovative treatment options.
NovaVision's top competitors include Newronika, Sight Science and Actipulse Neuroscience.
NovaVision offers Vision Restoration Therapy (VRT) and NeuroEyeCoach.
NovaVision has made 1 acquisition, including Sight Science.
NovaVision has 5 investors. Key investors include Johnson & Johnson Innovation – JJDC, Oakwood Medical, Tullis Health Investors, Noro-Moseley Partners, and Crossbow Ventures.